Living Skin Probiotic Program
Acne
Key Facts
About S-biomedic
S-Biomedic is a pioneering private biotech company developing live skin probiotics and postbiotics derived from the skin's most abundant bacterium, Cutibacterium acnes. The company's platform aims to treat conditions like acne by modulating the skin microbiome to restore its natural, healthy balance, moving beyond conventional dermatological treatments. It has validated its approach through over 15 clinical studies and has established a significant partnership with Beiersdorf, which recently acquired the company. S-Biomedic's first commercial program, Sencyr®, is a microbiome care system for acne-prone skin.
View full company profileAbout S-biomedic
S-Biomedic is a pioneering private biotech company developing live skin probiotics and postbiotics derived from the skin's most abundant bacterium, Cutibacterium acnes. The company's platform aims to treat conditions like acne by modulating the skin microbiome to restore its natural, healthy balance, moving beyond conventional dermatological treatments. It has validated its approach through over 15 clinical studies and has established a significant partnership with Beiersdorf, which recently acquired the company. S-Biomedic's first commercial program, Sencyr®, is a microbiome care system for acne-prone skin.
View full company profileAbout S-biomedic
S-Biomedic is a pioneering private biotech company developing live skin probiotics and postbiotics derived from the skin's most abundant bacterium, Cutibacterium acnes. The company's platform aims to treat conditions like acne by modulating the skin microbiome to restore its natural, healthy balance, moving beyond conventional dermatological treatments. It has validated its approach through over 15 clinical studies and has established a significant partnership with Beiersdorf, which recently acquired the company. S-Biomedic's first commercial program, Sencyr®, is a microbiome care system for acne-prone skin.
View full company profileTherapeutic Areas
Other Acne Drugs
| Drug | Company | Phase |
|---|---|---|
| Novel Anti-acne Therapeutics (with Curl Bio) | ZenBio | Pre-clinical |
| B244 | AOBiome | Phase 2 |
| ADA-308 | Aranda Pharma | Pre-clinical |
| Vincobiosis® Acneic | Laboratorio Reig Jofre | Launched |
| BTX 1503 | Botanix Pharmaceuticals | Phase 2 |
| Pyrilutamide | Kintor Pharma | Phase 2 |